Account Prostate Specific Antigen Substrate
- Catalog No. :
- ACSCNA817
- CAS No. :
- 380225-52-5
- Molecular Formula :
- C44H64N12O13
- Molecular Weight :
- 969.07
IUPAC Name:(S)-2-((3S,6S,9S,12S,15S)-3-((1H-imidazol-5-yl)methyl)-12-(4-aminobutyl)-6,9-bis(hydroxymethyl)-15-isobutyl-1-morpholino-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecan-16-amido)-N1-(4-methyl-2-oxo-2H-chromen-7-yl)pentanediamide
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$242.00Login to see priceInquiryInquiry
5mg98%$605.00Login to see priceInquiryInquiry
10mg98%$874.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | Prostate Specific Antigen Substrate |
|---|---|
| IUPAC Name | (S)-2-((3S,6S,9S,12S,15S)-3-((1H-imidazol-5-yl)methyl)-12-(4-aminobutyl)-6,9-bis(hydroxymethyl)-15-isobutyl-1-morpholino-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecan-16-amido)-N1-(4-methyl-2-oxo-2H-chromen-7-yl)pentanediamide |
| Molecular Formula | C44H64N12O13 |
| Molecular Weight | 969.07 |
| SMILES | CC1=CC(=O)OC2=C1C=CC(NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)NC(=O)N1CCOCC1)=C2 |
| InChI Key | NEIZLGXRBMPOOJ-CVUOCSEZSA-N |
| Synonym | Prostate Specific Antigen Substrate;L-Glutamamide, N-(4-morpholinylcarbonyl)-L-histidyl-L-seryl-L-seryl-L-lysyl-L-leucyl-N1-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)- |
| CAS No. | 380225-52-5 |
Synthetic Route by SureRoute
2. ACSCNA817 Molecular Building Block Synthetic Route
(S)-N-((S)-3-(1H-imidazol-5-yl)-1-((S)-2-((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide
(4S,7S,10S,13S)-10-((1H-Imidazol-5-yl)methyl)-7-(2-carboxyethyl)-4-isobutyl-13-((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oic acid compound with 2,2,2-trifluoroacetic acid (1:1)
(4S,7S,10S,13S)-10-((1H-imidazol-4-yl)methyl)-7-(2-carboxyethyl)-4-isobutyl-2,5,8,11-tetraoxo-13-((2-oxo-4-(trifluoromethyl)-2H-chromen-7-yl)carbamoyl)-3,6,9,12-tetraazapentadecan-15-oic acid--2,2,2-trifluoroacetic acid (1/1)